These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 352747)
41. [The role of Agreal in the treatment of the menopause]. Marais C Rev Fr Gynecol Obstet; 1985 Feb; 80(3):156-62. PubMed ID: 3992113 [TBL] [Abstract][Full Text] [Related]
42. [Estrogen treatment only when symptoms are present but complaints should not be neglected]. Widholm O Nord Med; 1977 May; 92(5):153. PubMed ID: 866107 [TBL] [Abstract][Full Text] [Related]
43. The menopause and climacteric: endocrinologic basis and associated symptomatology. Soules MR; Bremner WJ J Am Geriatr Soc; 1982 Sep; 30(9):547-61. PubMed ID: 7050219 [No Abstract] [Full Text] [Related]
45. Changing concepts in the management of the menopause. Greenblatt RB; Emperaire JC Med Times; 1970 Jun; 98(6):153-64. PubMed ID: 5446120 [No Abstract] [Full Text] [Related]
46. Climacteric. Pearson L Am J Nurs; 1982 Jul; 82(7):1098-102. PubMed ID: 6920233 [No Abstract] [Full Text] [Related]
47. [Some observations on the appearance of arteriosclerosis in the menopause]. MANFREDI P Rass Int Clin Ter; 1962 Jun; 42():637-46. PubMed ID: 14469255 [No Abstract] [Full Text] [Related]
48. Estrogen-androgen substitution therapy in the aged female. II. Clinical response. MASTERS WH; GRODY MH Obstet Gynecol; 1953 Aug; 2(2):139-47. PubMed ID: 13087904 [No Abstract] [Full Text] [Related]
50. Climacteric symptoms in an unselected sample of Swedish women. Hammar M; Berg G; FĂ„hraeus L; Larsson-Cohn U Maturitas; 1984 Dec; 6(4):345-50. PubMed ID: 6533438 [TBL] [Abstract][Full Text] [Related]
51. The pros and cons of estrogen administration after the menopause. SHELTON EK J Am Geriatr Soc; 1956 Apr; 4(4):348-57. PubMed ID: 13306512 [No Abstract] [Full Text] [Related]
52. Estrogen replacement therapy. Universal remedy for the postmenopausal woman? Beauchamp PJ; Held B Postgrad Med; 1984 May; 75(7):42-9, 52-3. PubMed ID: 6538966 [TBL] [Abstract][Full Text] [Related]
53. [Peroral treatment with natural human estrogens in the climacteric]. Sele V; Obel E Ugeskr Laeger; 1980 Sep; 142(38):2497-500. PubMed ID: 7445154 [TBL] [Abstract][Full Text] [Related]
54. [Psychometric aspects of estrogen therapy in the climacteric. Quantification of the psychotropic effect of hormones in 122 women (author's transl)]. Wenderlein JM MMW Munch Med Wochenschr; 1980 Mar; 122(12):419-22. PubMed ID: 6769003 [TBL] [Abstract][Full Text] [Related]
55. Estrogen therapy of perimenopausal and postmenopausal patients. Magera BE; Amerson AB; Wilson E Am J Hosp Pharm; 1979 Aug; 36(8):1062-71. PubMed ID: 384786 [No Abstract] [Full Text] [Related]
56. Menopause-specific quality of life across varying menopausal populations with conjugated estrogens/bazedoxifene. Abraham L; Pinkerton JV; Messig M; Ryan KA; Komm BS; Mirkin S Maturitas; 2014 Jul; 78(3):212-8. PubMed ID: 24837362 [TBL] [Abstract][Full Text] [Related]
57. The climacteric and some of its problems. Goldfarb AF Geriatrics; 1969 May; 24(5):107-16. PubMed ID: 5769661 [No Abstract] [Full Text] [Related]
58. [Changes in urinary NAG activity in patients with climacteric syndrome treated with estrogens]. Cottone G; Laterza G; Gallo G; Re M; Ronchi F; Zappi P; Scibinetti F; Russo G; Amici A; Clemenzia G Minerva Med; 1987 Mar; 78(6):399-402. PubMed ID: 3561850 [TBL] [Abstract][Full Text] [Related]